The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
The Intermountain Healthcare Supply Chain Organization has embarked on strategy to drive costs out of the healthcare supply chain. As a part of that…
On-Demand Educational Webinars
The supply chain ecosystem has contributed to the 25% waste in the health care system. We can accept that reality while at the same time learning to…
On-Demand Educational Webinars
In order to become data-driven organizations, healthcare providers need to leverage data standards and information technology.
On-Demand Educational Webinars
Although suppliers and providers may hesitate at a partnership approach, it is possible to collaborate on total cost of ownership. Learn from the…
Podcasts
Learn about how the significant number of clinical alarms have a numbing effect on nursing staff, to the point that patient safety is in jeopardy.
On-Demand Educational Webinars
Supply chain leaders are being charged with mission-critical tasks that require C-suite level engagement and buy-in. In this webinar, we discuss how…